AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.77+0.55 (+3.61%)
Close on Nov 17, 2026Market cap $487.72MP/E –Yield –
AVITA Medical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
AVITA Medical's pe ratio was 14.3× on Jan 31, 2024, against 8.0× a year earlier. Over the last 4 years it ranged from 4.1× to 26.5×, with a median of 10.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 14.3× | +2.6 |
| 2023 | Dec 29, 2023 | 11.7× | +6.1 |
| 2022 | Dec 30, 2022 | 5.6× | −4.6 |
| 2021 | Dec 31, 2021 | 10.2× | +0.3 |
| 2020 | Oct 30, 2020 | 9.9× | −16.6 |
| 2019 | Oct 31, 2019 | 26.5× | +22.4 |
| 2018 | Dec 31, 2018 | 4.1× | – |
See a number that looks wrong?